US Sends Experimental Ebola Drug to Congo
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"US Sends Experimental Ebola Drug to Congo" is generating significant coverage in the Health category, with 1 articles from 1 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Newser. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 105d ago.
Quick answers
Why is "US Sends Experimental Ebola Drug to Congo" trending?
Because 1 independent news sources published 1 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (1)
- US Sends Experimental Ebola Drug to Congo Newser · 140d ago
Topics
Related trends
Ebola in DR Congo: Millions of dollars going missing as virus spreads, MSF warns
Millions of dollars are going missing as a rapid Ebola epidemic spreads across the Democratic Republic of Congo.
Kenya's Ebola outbreak: Last patient discharged as countdown begins to be being declared free of the virus
Kenya discharges its final Ebola patient, initiating a 42-day countdown toward an official disease-free status declaration.
Ebola tops 11,000 cases in Congo’s deadliest outbreak
Congo's Ebola outbreak has reached 11,042 confirmed cases and 5,387 deaths, making it the deadliest in the country's history and the second-largest globally.
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
Eli Lilly's experimental triple-hormone drug retatrutide cut knee osteoarthritis pain and produced average weight loss of roughly 25% in two Phase 3 trials involving more than 1,000 adults with obesity.
Islamist militants force Ebola patients to flee in deadly Congo raid
Islamist militants of the Allied Democratic Forces attacked villages in North Kivu, killing dozens and forcing Ebola patients to abandon treatment centers.
Breakthrough: FDA Approves First Drug Offering a 'Functional Cure' For Chronic Hepatitis B
The US Food and Drug Administration and Health Canada have approved bepirovirsen, marketed as Hibsago, as the first functional cure for chronic hepatitis B.